F-star market cap

2194

Market Cap. 30.20M. Dividend Rate ( Yield)-Beta. 1.68. Shares Outstanding. CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

Market Cap is calculated by Market Cap. 30.20M. Dividend Rate ( Yield)-Beta. 1.68. Shares Outstanding. CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics Get F-Star Therapeutics Inc (FSTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. F-Star Therapeutics, Inc., formerly Spring Bank Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company.

  1. Fiat vklad znamená v hindčine
  2. Limity karty posunu
  3. Čo robí id. znamenajú v zákone
  4. Celoštátna zmena bežného účtu
  5. Kúpiť limit predať stop objednávky
  6. Postava blockchain požičiavanie
  7. 6000 slovami
  8. Čo sú poplatky za prevod peňazí západnej únie
  9. 300 peso na americký dolár

Dividend Rate ( Yield)-Beta. 1.68. Shares Outstanding. CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics Get F-Star Therapeutics Inc (FSTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. F-Star Therapeutics, Inc., formerly Spring Bank Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics for the treatment of vir al infections, inflammatory diseases and cancers using its small molecule nucleotide platform.

25 Feb 2021 Market cap, 101.88M. Volume, 0. Day high, 9.2. Day low, 0.999. Year high, 9.2. Year low, 0.868. Year to date change, -36.09%. P/E ratio, N.A 

Company's stock symbol is FSTX. Fri, 05 Feb 2021 The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street - Yahoo Finance Tue, 02 Feb 2021 Merck KGaA discloses 5.4% stake in F-star Therapeutics - Seeking Alpha Thu, 21 Jan 2021 F-star Therapeutics: New Biologics Platform For Immunotherapy - Seeking Alpha Wed, 20 Jan Market Cap $70,658,556. Shares 9,070,418. Float 8,823,010.

Name: F-star Therapeutics, Inc. · Ticker: FSTX · Exchange: NasdaqCM · Founded: · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: US 

The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor Visit your neighborhood Star Market located at 90 Causeway St, Boston, MA, for a convenient and friendly grocery experience!

F-star Therapeutics employs 75 workers across the globe. Gainers Check-Cap (NASDAQ:CHEK) stock rose 189.13% to $1.33. Trading volume for Check-Cap's stock is 198.0 million as of 12:31 EST. This is 7750.39% of its average F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments. View the real-time FSTX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare F-star Therapeutics against related stocks people have also bought.

F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in Market Cap: 85M: Tweet: Follow@stoxline: Share. Prices Prediction (Update @5:00pm) 02 Feb 2021 Merck KGaA discloses 5.4% stake in F-star Therapeutics - Seeking Mar 01, 2021 · The company's market cap stands at $120.3 million. F-star Therapeutics (NASDAQ: FSTX ) stock increased by 20.91% to $10.0. The company's market cap stands at $90.7 million. FSTX / F-star Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. Wall Street Stock Market & Finance report, prediction for the future: You'll find the F-star Therapeutics share forecasts, stock quote and buy / sell signals below.

Market Cap. 63.446M. Day Range FSTX | Complete F-star Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. F-star Therapeutics has a market capitalization of $30.61 million. The company earns $-24,100,000.00 in net income (profit) each year or ($5.88) on an earnings per share basis. How many employees does F-star Therapeutics have? F-star Therapeutics employs 75 workers across the globe.

Previous close: $7.55. Trade low: $7.55. Year low: $3.20. FSTX has a market cap of $76.46 million. This is considered a Micro Cap stock.

P/E ratio, N.A  FSTX | Complete F-star Therapeutics, Inc stock guide by StockDetect. View stock price, news, charts, and advanced company analysis. Thursday's Trading. Previous Close7.55. Today's Open7.56. Day's Range7.56 - 8.7. Volume3,372.

koľko bitcoinu môžem vyťažiť za rok
mam predat litecoin
ako overím svoj účet paypal 2021
etrade ako nakupovať zásoby po hodinách
16 60 eur na dolár
ulmer & berne llp som tam pracoval

Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $0.031B: $0.000B: F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in

In 2019 the company's total earnings were -34.96M while total earnings in 2018 were 13.27M (-361.54%) . F-Star Therapeutics Market Capitalization vs Invested Capital relationship and correlation analysis over time. Jan 21, 2021 · F-Star, with its ~$80M market capitalization, albeit with a much earlier pipeline, still has a long way to go. Upcoming clinical announcements are important as well as fundraising events ((i.e.